It is known that a build-up of Amyloid plaques in the brain is common in Alzheimer’s patients, but what do they affect? Scientists at Israel’s Ben Gurion University have just found that they are a catalyst to the degradation of neurotransmitters such as dopamine and adrenaline.

https://in.bgu.ac.il/en/pages/news/Amyloid-Plaques-Alzheimer.aspx

https://www.sciencedirect.com/science/article/pii/S2667109321001366?via%3Dihub